The Cranbury, New Jerseybased biotech announced FDA acceptance of its Biologics License Application for RP-L201 (marnetegragene autotemcel), an investigational lentiviral vector (LV)-based gene therapy for LAD-I, a rare, genetic immune disorder that predisposes patients to frequent and often fatal infections
Get baseline labs
Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics
Patients achieve incredible results with GLP-1 medications Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) or through gastric sleeve and revision surgery
This guide, from a London consultant eye surgeon, explains whats normal, what isnt, and exactly when to get your eyes checked
WSAVA Global Nutrition Committee